| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.800 | None | 0.600 | 6 | 0 | 1997 | 2018 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.740 | None | 1.000 | 6 | 0 | 2004 | 2017 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.800 | 9 | 6 | 2008 | 2020 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.700 | None | 1.000 | 8 | 33 | 2008 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.700 | None | 1.000 | 6 | 0 | 1997 | 2019 | ||||||||
|
neurocan | 0.670 | 0.500 | 6.8E-02 |
|
disease | 0.680 | None | 1.000 | 6 | 2 | 2011 | 2019 | ||||||||
|
Sp4 transcription factor | 0.711 | 0.423 | 0.99 |
|
disease | 0.630 | None | 1.000 | 2 | 1 | 2009 | 2019 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
disease | 0.620 | None | 1.000 | 2 | 1 | 2001 | 2018 | ||||||||
|
adenylate cyclase 2 | 0.695 | 0.308 | 1.00 |
|
disease | 0.620 | None | 1.000 | 2 | 11 | 2014 | 2019 | ||||||||
|
lectin, mannose binding 2 like | 0.641 | 0.385 | 2.0E-11 |
|
disease | 0.610 | None | 1.000 | 2 | 2 | 2013 | 2019 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
disease | 0.610 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 1.000 | 7 | 0 | 1995 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 7 | 0 | 2002 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.600 | None | 0.800 | 6 | 0 | 2004 | 2019 | ||||||||
|
dopamine receptor D1 | 0.529 | 0.808 | 0.96 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1992 | 2015 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2004 | 2017 | ||||||||
|
glutamate decarboxylase 1 | 0.486 | 0.885 | 4.6E-02 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2000 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2006 | 2015 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2000 | 2019 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 1 | 0.691 | 0.462 | 2.1E-31 |
|
disease | 0.600 | None | 1.000 | 3 | 3 | 2009 | 2019 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit V2 | 0.610 | 0.500 | 5.6E-03 |
|
disease | 0.590 | None | 1.000 | 5 | 0 | 2003 | 2015 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.580 | None | 0.800 | 6 | 1 | 2005 | 2019 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
disease | 0.570 | None | 1.000 | 8 | 0 | 2000 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.570 | None | 0.500 | 4 | 0 | 2000 | 2019 | ||||||||
|
G protein-coupled receptor kinase 3 | 0.621 | 0.731 | 0.71 |
|
disease | 0.560 | None | 1.000 | 6 | 0 | 2003 | 2010 |